Results 101 to 110 of about 1,862,216 (244)
Neoatherosclerosis as reason for stent failures beyond 5 years after drug-eluting stent implantation [PDF]
A 69-year-old male (case 1) was admitted due to acute non-ST-segment elevation myocardial infarction (NSTEMI). Eight years earlier, he had previously undergone treatment with a sirolimus-eluting stent (SES).
Taniwaki, Masanori +2 more
core +2 more sources
A multifunctional 3D‐printed polymer–ZrO2 scaffold is developed to provide intrinsic radiopacity, photothermal responsiveness, and surface bioactivity. Reinforcement with ZrO2 enables real‐time x‐ray visibility and mechanical robustness, while a polydopamine coating facilitates near‐infrared‐triggered drug release and modulates cell migration, thereby ...
Sumin Kang +10 more
wiley +1 more source
Drug-eluting stent: a review and update
Thein Htay, Ming W LiuDivision of Cardiovascular Medicine, Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USAAbstract: The development of stent has been a major advance in the treatment of obstructive
Ming W Liu, Thein Htay
core
Introduction Several treatment modalities have been proposed and used for bare-metal in-stent restenosis (ISR). We compared the efficacy of drug-eluting balloons (DEB) versus drug-eluting stents (DES) in the treatment of ISR in terms of binary restenosis,
Gautam Singal +2 more
core +1 more source
Diabetes mellitus: a prothrombotic state. Implications for outcomes after coronary revascularization
Clarissa Cola1, Salvatore Brugaletta1, Victoria Martín Yuste1, Bieito Campos1, Dominick J Angiolillo2, Manel Sabaté11Interventional Cardiology Unit, Department of Cardiology, Sant Pau University Hospital, Barcelona, Spain ...
Clarissa Cola +5 more
doaj
Drug Eluting Stent dan pemakaian Off-label
Revaskulasisasi koroner dengan PCI (Percutaneous Coronary Intervention) merupakan suatu cara yang sudah diterima sebagai alternatif bedah dalam mengatasi Penyakit Jantung Koroner (PJK).
Otte J Rachman
doaj +1 more source
Nonthermal plasma approaches for combating implant‐associated infections: A compendious review
Implant‐associated infections pose serious clinical challenges. Non‐thermal plasma (NTP) modifications overcome this bottleneck in distinct ways relative to traditional sterilization methods. Gas‐phase plasmas generate highly energetic species, UV radiation and reactive oxygen/nitrogen species (RONS), which alter the implant surface properties.
A. M. Trimukhe +8 more
wiley +1 more source
Interventional oncology in children: Where are we now?
Abstract Paediatric Interventional Oncology (IO) lags behind adult IO due to a scarcity of specific outcome data. The suboptimal way to evolve this field is relying heavily on adult experiences. The distinct tumour types prevalent in children, such as extracranial germ cell tumours, sarcomas, and neuroblastoma, differ strongly from those found in ...
Premal Amrishkumar Patel +1 more
wiley +1 more source
Is a Drug-Eluting Stent the Default Treatment Strategy for Drug-Eluting Stent Restenosis?∗
In 2001, when Morice et al. [(1)][1] presented the initial results of RAVEL (The Randomized Study With the Sirolimus-Coated Bx Velocity Balloon-Expandable Stent in the Treatment of Patients With De Novo Native Coronary Artery Lesions), showing 0% angiographic restenosis 6 months after ...
Colombo, Antonio, Ruparelia, Neil
openaire +2 more sources
Among patients with type 2 diabetes undergoing percutaneous coronary intervention, thiazolidinedione use was independently associated with a significantly reduced risk of a composite of myocardial infarction, stroke, and all‐cause death, notably without an increased risk of admission for heart failure. ABSTRACT Background Thiazolidinediones (TZD) are a
Jinkwon Kim +5 more
wiley +1 more source

